Picture of Biondvax Pharmaceuticals logo

BVXV — Biondvax Pharmaceuticals Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m-4.68%
3m+11%
6m+0.02%
1yr-55.58%
Volume Change (%)
10d/3m-95.22%
Price vs... (%)
52w High-71.6%
50d MA-12.87%
200d MA-30.87%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-41.77%
Return on Equity-222.91%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for BVXV

Keep an eye on the momentum at Biondvax Pharmaceuticals background image

Keep an eye on the momentum at Biondvax Pharmaceuticals

Anyone familiar with stock market screeners will know that shares in Biondvax Pharmaceuticals (NAQ:BVXV) have been in an uptrend in recent months, with strong relative price strength on a 1-month, 6-month and 12-month basis.Finding sto...

Could Biondvax Pharmaceuticals (NAQ:BVXV) be a turtle trade? background image

Could Biondvax Pharmaceuticals (NAQ:BVXV) be a turtle trade?

Ever since the 1980s, when the now-infamous "Turtle Traders" beat the market with simple strategies based on breakouts to new high prices, momentum investing has been shown to be a very profitable strategy.  In fact, many academics now...

Could Biondvax Pharmaceuticals (NAQ:BVXV) be a turtle trade? background image

Could Biondvax Pharmaceuticals (NAQ:BVXV) be a turtle trade?

Ever since the 1980s, when the now-infamous "Turtle Traders" beat the market with simple strategies based on breakouts to new high prices, momentum investing has been shown to be a very profitable strategy.  In fact, many academics now...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biondvax Pharmaceuticals EPS forecast chart

Profile Summary

BiondVax Pharmaceuticals Ltd is an Israel-based is Phase 3 clinical phase biopharmaceutical company. It is developing the M-001 Universal Flu Vaccine. M-001 is undergoing a pivotal, clinical efficacy, Phase 3 trial in about 12,400 participants. M-001 is designed to provide multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic. In 6 completed clinical trials the vaccine was shown to be safe, well tolerated and immunogenic to a broad range of flu strains. The Company’s technology utilizes a proprietary combination of conserved and common peptides from influenza virus proteins to activate both arms of the immune system for a cross-protecting and long-lasting effect.

Directors

    Last Annual
    December 31st, 2021
    Last Interim
    March 31st, 2022
    Incorporated
    July 22nd, 2003
    Public Since
    July 7th, 2007
    No. of Employees
    17
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    745,048,544
    Blurred out image of a map
    Address
    Jerusalem Biopark, JERUSALEM, 00000
    Web
    http://www.biondvax.com
    Phone
    +972 89302529
    Contact
    Joshua Phillipson
    Auditors
    Kost, Forer, Gabbay & Kasierer

    BVXV Share Price Performance

    Upcoming Events for BVXV

    Similar to BVXV

    Picture of 180 Life Sciences logo

    180 Life Sciences

    us flag iconNASDAQ Capital Market

    Picture of 9 Meters Biopharma logo

    9 Meters Biopharma

    us flag iconNASDAQ Capital Market

    Picture of Abeona Therapeutics logo

    Abeona Therapeutics

    us flag iconNASDAQ Capital Market

    Picture of ABVC Biopharma logo

    ABVC Biopharma

    us flag iconNASDAQ Capital Market

    Picture of Acer Therapeutics logo

    Acer Therapeutics

    us flag iconNASDAQ Capital Market

    FAQ

    Or unlock with your email

    Or unlock with your email